Propafenone Pregnancy and Breastfeeding Warnings
Propafenone Pregnancy Warnings
FDA pregnancy category: C Use propafenone only if clearly needed and benefit outweighs potential risk.
Animal studies have revealed evidence of embryotoxicity, but no teratogenicity after administration of dosages 10 to 40 times the maximum recommended human dose (on a per kg basis). There are no controlled data in human pregnancy. Limited data indicate that propafenone has been administered during the third trimester of pregnancy without adverse maternal or fetal effects. Propafenone should be given during pregnancy only when benefit outweighs risk. Both propafenone and 5-hydroxypropafenone cross the placenta. Two cases describing the use of propafenone 900 mg daily during pregnancy are reported. The placental blood or umbilical cord to maternal plasma drug concentration ratios were 0.1 to 0.3 for propafenone and 0.4 to 0.5 for 5-hydroxypropafenone in each case. Unbound drug and metabolite freely cross the placenta, with cord and maternal plasma concentrations approximately equal. No harmful effects on the human fetus have been reported during the third trimester of pregnancy, but data are limited. Data are unavailable regarding the use of propafenone earlier in pregnancy. Increased maternal alpha-1-acid glycoprotein serum levels are expected during and after pregnancy. This may result in increased plasma protein binding of propafenone, although the clinical importance of this is not known.
Propafenone Breastfeeding Warnings
In one case, 3 days following propafenone dosing the milk to maternal plasma concentration ratios were 0.15 and 0.55 for propafenone and 5-hydroxypropafenone, respectively. An intake of 150 mL/kg/day of maternal milk would result in a nursing infant exposure of 16 to 24 mcg per day.
Use of propafenone is not recommended. Excreted into human milk: Yes Excreted into animal milk: Unknown The effects in the nursing woman are not known.
- Propafenone use while Breastfeeding (in more detail)
- propafenone Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.